Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$100.58 - $112.38 $1.68 Million - $1.87 Million
-16,673 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $65,888 - $84,570
662 Added 4.13%
16,673 $1.73 Million
Q3 2021

Nov 10, 2021

SELL
$122.75 - $135.17 $69,476 - $76,506
-566 Reduced 3.41%
16,011 $2.01 Million
Q2 2021

Aug 17, 2021

SELL
$118.19 - $131.5 $404,564 - $450,124
-3,423 Reduced 17.12%
16,577 $2.06 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $317,931 - $353,735
2,690 Added 15.54%
20,000 $1.21 Million
Q1 2021

May 12, 2021

SELL
$111.18 - $119.74 $173,107 - $186,435
-1,557 Reduced 8.25%
17,310 $2.05 Million
Q4 2020

Feb 08, 2021

BUY
$100.57 - $117.14 $1.9 Million - $2.21 Million
18,867 New
18,867 $2.21 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Waycross Partners, LLC Portfolio

Follow Waycross Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.